Glioblastoma is the most prevalent and aggressive brain tumor. It proliferates very rapidly, is highly invasive, and there is currently no treatment capable of halting its progression or curing it, ...

A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by ...

Half of patients with GBM present with headaches at diagnosis, which is attributed to increases in intracranial pressure (Table 2). 11 Papilledema, now rarely seen because imaging is typically ...

A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Treatment Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global Glioblastoma Multiforme (GBM) ...

Correctly distinguishing between look-alike tumors found in the brain during surgery can guide critical decisions in real time while patient is still in the operating room. A new AI tool outperformed ...

Chicago, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The global glioblastoma multiforme treatment market was valued at 3.0 billion in 2024 and is expected to reach US$ 6.1 billion by 2033, growing at a CAGR of ...

Temferon demonstrated potential in glioblastoma treatment, with long-term survivors and improved survival rates compared to historical data. The therapy reprograms the tumor microenvironment, inducing ...

A 57-year-old UK father of four recently made headlines when he revealed the bizarre clue that preceded his Stage 4 glioblastoma diagnosis — a “strange sweet caramel smell.” “We didn’t think much of ...